Physiologically-Based Pharmacokinetic Modeling of the PARP Inhibitor Niraparib.
Saved in:
| Title: | Physiologically-Based Pharmacokinetic Modeling of the PARP Inhibitor Niraparib. |
|---|---|
| Authors: | Lewis GJ; GlaxoSmithKline, DMPK, Preclinical Sciences, Stevenage, UK., Jewell RC; GlaxoSmithKline, Clinical Pharmacology Modelling and Simulation, Durham, North Carolina, USA., Krishnatry AS; GlaxoSmithKline, Clinical Pharmacology Modelling and Simulation, Upper Providence, Pennsylvania, USA., Taskar KS; GlaxoSmithKline, DMPK, Preclinical Sciences, Stevenage, UK. |
| Source: | CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2026 Jan; Vol. 15 (1), pp. e70182. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print Cited Medium: Internet ISSN: 2163-8306 (Electronic) Linking ISSN: 21638306 NLM ISO Abbreviation: CPT Pharmacometrics Syst Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2163-8306 |
|---|---|
| DOI: | 10.1002/psp4.70182 |
